Noopur Raje, MD: Denosumab Versus ZA for Myeloma-Related Bone Disease

Dr. Raje discusses results from a large phase III trial comparing denosumab with zoledronic acid for delaying the time to a skeletal-related complication in patients with myeloma.

SHARE